Indications
Parkinson’s disease
Amantadine Hydrochloride is indicated for-
Treatment of parkinsonism
Treatment of drug-induced extrapyramidal reactions
Prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus
Dosage And Administration
Parkinson's disease:
Adult: Initially, 100 mg/day, increased to 100 mg bid after a wk or more. Max dose: 400 mg daily.
Elderly: >65 yr: Lowest effective dose.
Prophylaxis of influenza A:
Adult: 100 mg daily for up to 6 wk; when used with influenza vaccination: only up to 3 wk after vaccination.
Child: 10-15 yr: 100 mg daily.
Influenza A:
Adult: 100 mg daily for 5 days.
Elderly: >65 yr: Daily dose of 1 day.
Herpes zoster in immunocompromised patients:
Adult: 100 mg bid for 14 days, continued for another 14 days if pain persists.
Side Effects
The adverse effects of Amantadine are generally mild and, when they occur, may diminish or cease after a week or more on the medication. The most commonly reported side effects include nausea, dizziness/ lightheadedness, and insomnia.
Other side effects may include edema of ankles, livedo reticularis; anxiety, elevation of mood, headache, lethargy, hallucinations, ataxia, slurred speech, blurred vision, loss of concentration, nervousness, depression, myalgia, palpitations, orthostatic hypotension, dry mouth, anorexia, constipation and diaphoresis.
Precautions And Warnings
Amantadine should not be discontinued abruptly in patients with Parkinson's disease since a few patients have experienced a parkinsonian crisis, i.e., a sudden marked clinical deterioration, when this medication was suddenly stopped. The dose of anticholinergic drugs or of Amantadine Hydrochloride should be reduced if atropine-like effects appear when these drugs are used concurrently. Abrupt discontinuation may also precipitate delirium, agitation, delusions, hallucinations, paranoid reaction, stupor, anxiety, depression and slurred speech.
Pregnancy And Lactation
Pregnancy category C. No well-controlled studies have been done in pregnant women to evaluate Amantadine's safety. Amantadine may be used during pregnancy when the potential benefits outweigh the potential but unknown risks to the fetus.
Amantadine is excreted into breast milk in low concentrations. As no information is available on the effects in infants, therefore amantadine should be used cautiously in women who are breastfeeding.